Conditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia
(AML) following allogeneic hematopoietic cell transplantation (HCT). In early times …

The long-standing debate of whether patients with acute myeloid leukemia (AML) should
proceed to allogeneic hematopoietic cell transplantation (HCT) during first complete …

To investigate optimal unit selection for umbilical cord blood transplantation (UCBT), we
conducted a registry-based study of 1355 adults with acute myeloid leukemia in first or …

The aim of this study was to develop a comprehensive system for predicting non-relapse
mortality after allogeneic hematopoietic cell transplantation (HCT) during first complete …

Autologous hematopoietic cell transplantation (HCT) has not gained universal popularity in
the treatment of acute myeloid leukemia (AML), and its status remains unclear. To determine …

It remains unclear how specific innovations in allogeneic hematopoietic cell transplantation
(HCT) attained over the past decades have contributed to improvement in transplantation …

The net benefits of induction therapy for older adults with acute myeloid leukemia (AML)
remain controversial. Because AML in older adults is a heterogeneous disease, it is …

Hematopoietic stem cell transplantation (HSCT) and consolidation chemotherapy have been
used to treat intermediate-risk acute myeloid leukemia (AML) patients in first complete …

This study aimed to investigate time-varying effects of graft type on outcomes for patients
with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant. For this …

The present study evaluated outcomes and prognostic factors in adult patients with acute
myeloid leukemia (AML) after syngeneic hematopoietic stem cell transplantation (HSCT) …